Ruxolitinib in Patients With Corticosteroid-Refractory or Corticosteroid-Dependent Chronic Graft-Versus-Host Disease: 3-Year Final Analysis of the Phase III REACH3 Study Our phase II trial randomly ...
This study is the first randomized control trial to rigorously test a sequential approach to treating comorbid PTSD and major depressive disorder. Findings from a trial of 52 patients undergoing three ...
Please provide your email address to receive an email when new articles are posted on . CHICAGO — A sequential schedule of fixed-dose pembrolizumab with chemoradiotherapy conferred numerically higher ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback